"Tobramycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.
| Descriptor ID |
D014031
|
| MeSH Number(s) |
D09.408.051.476.600.800
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tobramycin".
Below are MeSH descriptors whose meaning is more specific than "Tobramycin".
This graph shows the total number of publications written about "Tobramycin" by people in this website by year, and whether "Tobramycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 1 | 1 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tobramycin" by people in Profiles.
-
Durrani AF, Atta S, Bhat AK, Mammen A, Dhaliwal D, Kowalski RP, Jhanji V. Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes. Am J Ophthalmol. 2020 06; 214:119-126.
-
Wu AY, Gervasio KA, Gergoudis KN, Wei C, Oestreicher JH, Harvey JT. Conservative therapy for chalazia: is it really effective? Acta Ophthalmol. 2018 Jun; 96(4):e503-e509.
-
Padegimas EM, Narzikul A, Lawrence C, Hendy BA, Abboud JA, Ramsey ML, Williams GR, Namdari S. Antibiotic Spacers in Shoulder Arthroplasty: Comparison of Stemmed and Stemless Implants. Clin Orthop Surg. 2017 Dec; 9(4):489-496.
-
Locke JB, Zuill DE, Scharn CR, Deane J, Sahm DF, Denys GA, Goering RV, Shaw KJ. Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene. Antimicrob Agents Chemother. 2014 Nov; 58(11):6592-8.
-
Chen AF, Parvizi J. Antibiotic-loaded bone cement and periprosthetic joint infection. J Long Term Eff Med Implants. 2014; 24(2-3):89-97.
-
Hansen EN, Adeli B, Kenyon R, Parvizi J. Routine use of antibiotic laden bone cement for primary total knee arthroplasty: impact on infecting microbial patterns and resistance profiles. J Arthroplasty. 2014 Jun; 29(6):1123-7.
-
Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2011 Oct; 118(10):2028-34.
-
Onder AM, Chandar J, Billings A, Simon N, Gonzalez J, Francoeur D, Abitbol C, Zilleruelo G. Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks. Pediatr Nephrol. 2009 Nov; 24(11):2233-43.
-
Onder AM, Chandar J, Simon N, Diaz R, Nwobi O, Abitbol CL, Zilleruelo G. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia. Nephrol Dial Transplant. 2008 Aug; 23(8):2604-10.
-
Onder AM, Chandar J, Simon N, Saint-Vil M, Francoeur D, Nwobi O, Abitbol C, Zilleruelo G. Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks. Pediatr Nephrol. 2008 Mar; 23(3):457-64.